scholarly journals Clinical practice guidelines for the surgical treatment of rectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO)

2016 ◽  
Vol 29 (2) ◽  
Author(s):  
Nikolaos Gouvas
Keyword(s):  
Rectal Cancer ◽  
Clinical Practice ◽  
Surgical Treatment ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Consensus Statement ◽  
Medical Oncologists

Clinical Practice Guidelines for the Surgical Treatment of Patients With Lynch Syndrome

2017 ◽  
Vol 60 (2) ◽  
pp. 137-143 ◽  
Author(s):  
Daniel O. Herzig ◽  
W. Donald Buie ◽  
Martin R. Weiser ◽  
Y. Nancy You ◽  
Janice F. Rafferty ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Surgical Treatment ◽  
Lynch Syndrome ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines

scholarly journals Conflicts of Interest in Clinical Practice Guidelines: Accelerating an Evolution. An Endocrine Society Consensus Statement*

2018 ◽  
Vol 103 (12) ◽  
pp. 4339-4342 ◽  
Author(s):  
Christopher R McCartney ◽  
Clifford J Rosen
Keyword(s):  
Clinical Practice ◽  
Best Practices ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Development Process ◽  
Consensus Statement ◽  
Conflicts Of Interest ◽  
Best Interests ◽  
Endocrine Society ◽  
Open Payments

Abstract An analysis of the Endocrine Society’s clinical practice guidelines (CPGs) published from 2010 to 2017—presented by Irwig et al. in the current issue of The Journal of Endocrinology and Metabolism—suggested that the Endocrine Society met five of seven National Academy of Medicine (NAM) standards concerning financial conflicts of interest in CPGs. As current contributors to the Endocrine Society’s CPG efforts, we offer additional context related to the 2011 NAM standards and the current environment concerning industry support in medicine, and we comment on the nature of industry support received by the Society’s CPG authors according to Irwig and colleagues’ analysis of the Centers for Medicare and Medicaid Services’ Open Payments database. Perhaps most importantly, we outline the Society’s recent and ongoing efforts to enhance the value of its CPGs. Such efforts include a 2016 revision of CPG author conflict of interest rules—a change that was invisible to the investigatory methods used by Irwig et al.—in addition to other processes designed to enhance CPG objectivity. We conclude our commentary by recognizing that good-faith attempts to enhance transparency and to reduce conflicts of interest (real or apparent) in CPGs will ultimately serve the best interests of patients and providers; we confirm the Endocrine Society’s resolute commitment to providing high-quality, evidence-based clinical guidance via a CPG development process that faithfully accords with current CPG best practices.

scholarly journals Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2017 ◽  
Vol 28 ◽  
pp. iv22-iv40 ◽  
Author(s):  
R. Glynne-Jones ◽  
L. Wyrwicz ◽  
E. Tiret ◽  
G. Brown ◽  
C. Rödel ◽  
...  
Keyword(s):  
Rectal Cancer ◽  
Clinical Practice ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines

Rectal Cancer Clinical Practice Guidelines in Oncology

2005 ◽  
Vol 3 (4) ◽  
pp. 492 ◽  
Keyword(s):  
Rectal Cancer ◽  
Colon Cancer ◽  
Clinical Practice ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Multidisciplinary Approach ◽  
The Past ◽  
Recent Version ◽  
The U.S ◽  
Cancer Panel

In 2005, an estimated 40,340 new cases of rectal cancer will occur in the U.S., and experts estimate that during the same year, 56,290 people will die of rectal and colon cancer. As with colon cancer, however, mortality from rectal cancer has also decreased over the past 30 years. The NCCN Rectal Cancer Panel believes a multidisciplinary approach is necessary for effectively managing rectal cancer, an approach detailed here. For the most recent version of the guidelines, please visit NCCN.org

Sign in / Sign up

Export Citation Format

Share Document